MCM
MAIA icon

MAI Capital Management’s MAIA Biotechnology MAIA Stock Holding History

MAI Capital Management’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$945 Hold
675
– – ﹤0.01% 4201
2025
Q4 		$1.03K Hold
675
– – ﹤0.01% 3617
2025
Q3 		$1.04K Hold
675
– – ﹤0.01% 3489
2025
Q2 		$1.22K Hold
675
– – ﹤0.01% 3569
2025
Q1 		$1.03K Hold
675
– – ﹤0.01% 3126
2024
Q4 		$1.34K Buy
+675
New +$1.62K ﹤0.01% 3119

Other funds holding MAIA

SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MAI Capital Management's MAIA Position: Q1 2026 in Review

MAI Capital Management held its MAIA Biotechnology (MAIA) position steady in Q1 2026 at 675 shares worth $945. The position accounts for ﹤0.01% of the portfolio, ranked #4201.

MAI Capital Management first reported a position in MAIA in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.34K in Q4 2024. 33 funds tracked by Wall St. Rank hold MAIA as of Q1 2026.

  • MAI Capital Management held 675 shares of MAIA Biotechnology worth $945 as of Q1 2026.
  • MAI Capital Management left its MAIA Biotechnology share count unchanged in Q1 2026.
  • MAIA Biotechnology made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #4201 holding.
  • MAI Capital Management first reported a position in MAIA Biotechnology in Q4 2024 and has held it in 6 quarters since.
  • MAI Capital Management's MAIA Biotechnology position peaked at $1.34K in Q4 2024.
  • 33 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.